Digital Genome Market Size, Share, Outlook, and Opportunity Analysis, 2018-2026
The digital genome market is
anticipated to grow as a result of advancing technology and rising public
awareness regarding the use of genomes for the diagnosis of diseases like
cancer, diabetes, and Attention Deficit Hyperactivity Disorder (ADHD). For
instance, the National Human Genome Research Institute (NHGRI) started a
strategic planning process in February 2018 with the goal of establishing a
vision for genomics research in 2020 that will speed up scientific and medical
breakthroughs. To further expand the novel applications in human health and
disease treatments, the institute will involve experts and members of various
public communities in the development of this strategic planning.
Additionally, machine learning
and artificial intelligence techniques are currently being used to solve a
number of problems in genomics, including the annotation of Digital
Genome Market sequence elements, the identification of splice
sites, promoters, enhancers, and nucleosome positions. For instance,
Congenica's Sapientia platform for clinical genomic analysis prioritises and
annotates whole-exome sequencing variants to help with the diagnosis of rare
diseases.
In December 2017, Google unveiled
DeepVariant, an artificial intelligence (AI) tool that draws on sequencing data
to create a more accurate portrait of any individual's digital
genome market. In sequencing data, DeepVariant automatically detects
small insertion and deletion mutations as well as base-pair mutations. The
Canadian Genomics Cloud, a cutting-edge public cloud platform, was introduced
in February 2018 to enable Canadian researchers to safely store, share, and
analyse genomics data for new discoveries.
Comments
Post a Comment